Citronellic Acid

Citronellic Acid

SCHEMBL712982

CC(C)=CCC[C@@H](C)CC(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.55
ALDH1A1 P00352 2/20 0.55
GGPS1 O95749 2/20 0.48
FDPS P14324 2/20 0.48
TSHR P16473 1/20 0.46
USP2 O75604 1/20 0.45
GLA P06280 1/20 0.43
BHMT Q93088 1/20 0.41
FNTA P49354 2/20 0.40
FNTB P49356 2/20 0.40
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citronellic Acid SCHEMBL714852 1.00 ALOX15 (0.55) ALOX15ALDH1A1GGPS1FDPSTSHR
Citronellic Acid SCHEMBL193354 1.00 ALOX15 (0.55) ALOX15ALDH1A1GGPS1FDPSTSHR
Citronellic Acid SCHEMBL1375889 0.98 ALOX15 (0.53) ALOX15ALDH1A1GGPS1FDPSTSHR
Citronellic Acid SCHEMBL1375886 0.98 ALOX15 (0.53) ALOX15ALDH1A1GGPS1FDPSTSHR
SCHEMBL4640999 0.90 ALOX15 (0.50) ALOX15ALDH1A1GGPS1FDPSTSHR
SCHEMBL7942985 0.89 FNTA (0.56) ALDH1A1FNTAFNTBKDM4EATM
SCHEMBL7942988 0.89 FNTA (0.56) ALDH1A1FNTAFNTBKDM4EATM
SCHEMBL10405071 0.89 FNTA (0.56) ALDH1A1FNTAFNTBKDM4EATM
SCHEMBL1716801 0.89 FNTA (0.56) ALDH1A1FNTAFNTBKDM4EATM
SCHEMBL17047999 0.89 FNTA (0.56) ALDH1A1FNTAFNTBKDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
CN-115792012-B Method for detecting aroma components of rose syrup and method for measuring aroma component content of rose syrup 兰州海关技术中心 2024-12-20 CN claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 US claimed
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Indiana University Research and Technology Corpora tion (US) 2016-06-23 US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 US claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 US claimed
WO-2010118241-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2010-10-14 WO claimed
US-6916890-B1 Thermally reworkable epoxy resins and compositions based thereon HENKEL CORPORATION (US) 2005-07-12 US claimed
WO-2003031492-A1 THERMALLY REWORKABLE EPOXY RESINS AND COMPOSITIONS BASED THEREO N HENKEL CORPORATION (US) 2003-04-17 WO claimed
JP-62111937-A None JP disclosed
JP-63190839-A None JP disclosed
US-12551555-B2 Compositions and methods for potentiating immune activity KUMQUAT BIOSCIENCES INC. (US) 2026-02-17 US disclosed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP disclosed
CN-120157593-A Deuterated analogs of acetyl-leucine 内在生物技术有限公司 2025-06-17 CN disclosed
US-4786730-A Pyrimidine compound ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1988-11-22 US disclosed
JP-S63190839-A OPTICALLY ACTIVE ALCOHOL COMPOUND ADEKA ARGUS CHEM CO LTD 1988-08-08 JP disclosed
JP-S62111937-A PRODUCTION OF (R)-2,6-DIMETHYLALKENE-2 ADEKA ARGUS CHEM CO LTD 1987-05-22 JP disclosed
US-4123465-A SELECTIVE HYDROGENATION CATALYSTS HOFFMANN-LA ROCHE INC. (US) 1978-10-31 US disclosed
US-4115417-A ENANTIOSELECTIVITY HOFFMANN-LA ROCHE INC. (US) 1978-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS ALOX15 4290/4885ALDH1A1 3087/4885GGPS1 2433/4885
US-12551555-B2 Compositions and methods for potentiating immune activity PTPRCAP, PTPN2, PTPRC ALOX15 4434/4885ALDH1A1 4675/4885GGPS1 4474/4885
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS ALOX15 4290/4885ALDH1A1 3087/4885GGPS1 2433/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS ALOX15 4290/4885ALDH1A1 3087/4885GGPS1 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.